The Framingham function overestimates stroke risk for diabetes and metabolic syndrome among Spanish population;La escala de Framingham sobrevalora el riesgo cerebrovascular de la diabetes y el síndrome metabólico en la población Española

Atencion Primaria

Volumn 35, Issue 8, 2005, Pages 392-398

  Costa, B ^a,b   Cabre J J ^a   Martin F ^a   Pinol J L ^a   Basoray, J ^a   Blade J ^a  

^a INSTITUT CATALÀ DE LA SALUT   (Spain)

^b Centre Diabetis Salou   (Spain)

Author keywords

Diabetes; Metabolic syndrome; Stroke; Stroke risk; X syndrome

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COMPUTER ASSISTED DIAGNOSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; EDUCATION PROGRAM; FEMALE; FRAMINGHAM FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTICENTER STUDY; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SPAIN; STATISTICAL ANALYSIS; STROKE; WORLD HEALTH ORGANIZATION;

EID: 20444427974     PISSN: 02126567     EISSN: None     Source Type: Journal    
DOI: 10.1157/13074794     Document Type: Article

References (30)

1. Gresham GE, Kelly-Hayes M, Wolf PA, Beiser AS, Kase CS, D'Agostino RB. Survival and functional status 20 or more years after first stroke: the Framingham study. Stroke. 1998;29:793-7.
2. Gil AC. Nuevos enfoques terapéuticos en la prevención del ictus. Rev Neurol. 2002;35:801-4.
3. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-9.
4. Megherbi SE, Milan C, Minier D, Couvreur G, Osseby GV, Tilling K, et al. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. Stroke. 2003;34:688-94.
5. World Health Organization. Report of a WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization. Department of Noncommunicable Disease Surveillance; 1999.
6. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
7. Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham-Yudkin JS, Morris R, et al. The European Group for the Study of Insulin Resistance (EGIR). Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab. 2002;28:364-76.
8. Bloomgarden ZT. American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome: 25-26 august 2002, Washington DC. Diabetes Care. 2003;26:1297-303.
9. Grupo de Trabajo Resistencia a la Insulina de la Sociedad Española de Diabetes. Resistencia a la insulina y su implicación en múltiples factores de riesgo asociados a la diabetes tipo 2. Med Clin (Barc). 2002;119:458-63.
10. Costa B, Cabré JJ, Martín F. Síndrome metabólico, resistencia a la insulina y diabetes. ¿Qué se oculta bajo la punta del iceberg? Aten Primaria. 2003;31:436-45.
11. Alberti KG, Zimmet PZ, for the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-53.
12. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1992;22:312-8.
13. D'Agostino RB, Wolf PA, Belanger AJ, Kannel WB. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke. 1994;25:40-3.
14. Straus SE, Majumdar SR, McAlister FA. New evidence for stroke prevention: scientific review. JAMA. 2002;288:1388-95.
15. Álvarez Sabin J. Etiología y factores de riesgo del infarto cerebral. Rev Clin Esp. 1996;196 Supl 3:3-5.
16. Gil de Castro R, Gil Núñez AC. Factores de riesgo del ictus isquémico (I). Factores de riesgo convencionales. Rev Neurol. 2000;31:314-23.
17. Baird TA, Parsons MW, Alan Barber P, Butcher KS, Desmond PM, Tress BM, et al. The influence of diabetes mellitus and hyperglycaemia on stroke incidence and outcome. J Clin Neurosci. 2002;9:618-26.
18. Saitoh T, Daimon M, Eguchi H, Hosoya T, Kawanami T, Kurita K, et al. Type 2 diabetes is not a risk factor for asymptomatic ischemic brain lesion - the Funagata study. Intern Med. 2002;41:351-6.
19. Tomás L, Puig T, Balaguer I. Accidente vascular cerebral: incidencia, mortalidad y factores de riesgo en 28 anos de seguimiento. Estudio de Manresa. Rev Esp Cardiol. 2000;53:15-20.
20. Arboix A, Massons J, García-Eroles L, Oliveres M, Targa C. Diabetes is an independent risk factor for in-hospital mortality from acute spontaneous intracerebral hemorrhage. Diabetes Care. 2000;3:1527-32.
21. Arboix A, Morcillo C, GarcíEroles L, Oliveres M, Massons J, Targa C. Different vascular risk factor profiles in ischemic stroke subtypes: a study form the Sagrat Cor Hospital of Barcelona Stroke Registry. Acta Neurol Scand. 2000;102:264-70.
22. Rodríguez BL, D'Agostino R, Abbott RD, Kagan A, Burchfiel CM, Ross GW, et al. Risk of hospitalized stroke in men enrolled in the Honolulu Heart Program and the Framingham Study: a comparison of incidence and risk factor effects. Stroke. 2002;33:230-6.
23. The DECODE Study Group. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 european cohorts. Diabetes Care. 2003;26:61-9.
24. Matias-Guiu J. La epidemiología cerebrovascular. Rev Esp Cardiol. 2000;53:13-4.
25. Olindo S, Cabre P, Deschamps R, Chatot-Henry C, Rene-Corail P, Fournière P. Acute stroke in the very elderly. Epidemiological features, stroke subtypes, management, and outcome in Martinique, French West Indies. Stroke. 2003;34:1593-7.
26. Conthe P, Lobos JM, Gonzalez Juanatey JR, Gil A, Pajuelo FJ, Novials. A, et al. (Estudio ESPERANZA). Diferencias en la atención de las mujeres con alto riesgo cardiovascular respecto a los varones: estudio multidisciplinario. Med Clin (Barc). 2003;120:451-5.
27. Morin M, González R, Gil AC, Vivancos J. El ictus en la mujer. Epidemiología hospitalaria en España. Rev Neurol. 2003;37:701-5.
28. Maiques Galán A. ¿Qué riesgo coronario presentan nuestros pacientes diabéticos? Aten Primaria. 2002;29:205-12.
29. Straus SE, Majumdar SR, McAlister FA. New evidence for stroke prevention: clinical applications. JAMA. 2002;288:1396-8.
30. Marrugat J, Solanas P, D'Agostino R, Sullivan L, Ordovas J, Cordón F, et al. Estimación del riesgo coronario en España utilizando la ecuación de Framingham calibrada. Rev Esp Cardiol. 2003;56:253-61.